Therefore, modern anti-diabetic drugs, such as GLP-1RA, SGLT2 inhibitors, DPP-4 inhibitors, and biguanides, have been reported to be effective in achieving optimal metabolic control in OSA patients with diabetes. This evidence concerns the gene SLC5A2 and diabetes mellitus.